Return to top of page

Rally for Access

Published March 24, 2022

In June 2021, the Food and Drug Administration (FDA) approved a new treatment for Alzheimer’s disease–the first new therapy Alzheimer’s therapy in almost 20 years. But in January 2022, the Centers for Medicare and Medicaid Services (CMS) announced it has no plans to cover the treatment for most seniors. Even worse, CMS’ decision will extend to future FDA approved Alzheimer’s treatments in this class of drugs. So on March 15, 2022, patients and advocates gathered to make sure their voices were heard. This video shares highlights from the rally.

Related Alzheimer’s Disease Videos

Watch video

Webinar: Financing the Cure: Exploring the Ecosystem of Alzheimer’s Disease Research Funding

The Accelerate Cures/Treatments for All Dementias (ACT-AD) held a webinar on July 13, 2021 for an in-depth…

more.
Watch video

Webinar: Research and Clinical Development in Lewy Body Dementia

On December 7, 2020, ACT-AD held a webinar on cutting-edge research on Lewy Body dementia (LBD). The webinar…

more.
Watch video

Webinar: The Emerging Antimicrobial Protection Hypothesis of Alzheimer’s Disease

The Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD) Coalition held an educational webinar on April 18, 2019 on…

more.